Precision Biology Platform Market
Every Market-Reports.com study delivers in-depth market sizing, growth forecasts, competitive intelligence, segmentation analysis, and regional insights — built from company filings, government statistics and trade data, and structured for confident strategic decision-making. Request a free report preview to see its scope, chapters and methodology before you buy.
Market Snapshot
2025 Market Size
US$ 7.0 billion
Estimated Base Value
2035 Forecast
US$ 12.5 billion
Projected Market Value
CAGR 2026–2035
6.0%
Compound Annual Growth
Largest Segment
Genomic & Epigenomic Profiling Platforms
Fastest Growing Segment
Electric Commercial Vehicles
Leading Region
Asia Pacific
Fastest Growing Region
Asia Pacific
Top Country
United States
By Market Share
Largest market
Key Players
10x Genomics
Emerging Players
Generate Biomedicines, AbCellera
Precision Biology Platform Market Overview
The Precision Biology Platform market covers integrated technological ecosystems that accelerate and optimize drug discovery, development, and therapeutic research within the pharmaceutical industry. These platforms utilize advanced tools such as multi-omics, artificial intelligence, machine learning, and high-throughput techniques for precise manipulation, measurement, and analysis of biological systems. They enhance the understanding of disease mechanisms, identify novel drug targets, and facilitate the development of personalized medicines. Key buyers include pharmaceutical and biopharmaceutical companies, biotechnology firms, contract research organizations, and academic and research institutions seeking to improve R&D efficiency and predictability.
The Precision Biology Platform market is estimated at $7.0 Bn in 2025 and is forecast to reach $12.5 Bn in 2035, growing at a CAGR of 6.0% from 2025 to 2035. Demand is driven by the need for rapid and effective drug development solutions, advancements in genomic and proteomic technologies, and increased pharmaceutical R&D spending. Market expansion is constrained by high development and operational costs, stringent regulatory pathways, and the challenges associated with managing and interpreting complex biological datasets.
The market is segmented by Type (Genomic & Epigenomic Profiling Platforms, Proteomic & Metabolomic Analysis Platforms, Single-Cell & Spatial Biology Platforms, Synthetic Biology & Gene Editing Platforms, Cellular & Organoid Modeling Platforms, Bioinformatics & Data Integration Platforms), Technology (Next-Generation Sequencing, Mass Spectrometry, CRISPR-Cas Systems, Microfluidics & Lab-On-A-Chip, High-Throughput Screening, Flow Cytometry & Cell Sorting, Artificial Intelligence & Machine Learning, 3D Bioprinting), Application (Drug Discovery & Development, Disease Diagnostics & Prognostics, Personalized & Precision Medicine, Biomarker Discovery & Validation, Agricultural Biotechnology, Environmental Research, Forensic Science & Toxicology, Academic Research & Education), End-User (Pharmaceutical & Biopharmaceutical Companies, Biotechnology Companies, Contract Research Organizations, Academic & Research Institutions, Diagnostic Laboratories, Government & Regulatory Agencies, Food & Beverage Industry), Component (Instruments & Equipment, Reagents & Consumables, Software & Bioinformatics Solutions, Services, Automation & Robotics Modules, Data Storage & Management Systems), and Process (Target Identification & Validation, Lead Discovery & Optimization, Preclinical & Clinical Research, Drug Repurposing & Mechanism of Action Studies, Biomanufacturing Process Development, Biomarker & Companion Diagnostic Development, Gene & Cell Therapy Development). It is served across Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. Leading companies include 10x Genomics, Ginkgo Bioworks, Twist Bioscience, CRISPR Therapeutics, Intellia Therapeutics, Recursion Pharmaceuticals, Schrödinger, Exscientia, Pacific Biosciences (PacBio), NanoString Technologies, Seer, and SomaLogic. The full report covers market trends, drivers, restraints, and opportunities.
Market Definition & Overview
The Precision Biology Platform market within pharmaceuticals encompasses advanced, integrated technological ecosystems designed to accelerate and optimize drug discovery, development, and therapeutic research. These platforms leverage cutting-edge tools such as multi-omics, artificial intelligence, machine learning, and high-throughput techniques to achieve highly specific manipulation, measurement, and analysis of biological systems. Their primary function is to enhance the understanding of disease mechanisms, identify novel and precise drug targets, and facilitate the development of personalized medicines, thereby improving the efficiency, success rates, and predictability of the pharmaceutical R&D pipeline.
Scope
- Global geographic coverage including North America, Europe, Asia Pacific, and ROW.
- Focus on platforms adopted by pharmaceutical companies, biopharmaceutical firms, and academic research institutions.
- Market analysis covers the period from 2020 through 2033.
Inclusions
- Integrated hardware, software, and consumable systems for drug discovery.
- Multi-omics platforms (genomics, proteomics, metabolomics) for target identification.
- Artificial intelligence and machine learning tools for biological data analysis and prediction.
- High-throughput and high-content screening systems for compound evaluation.
- Gene editing technologies like CRISPR-Cas9 for therapeutic development.
- Single-cell and spatial biology platforms for cellular characterization.
Exclusions
- Generic laboratory equipment not part of an integrated platform.
- Standalone contract research services lacking proprietary platform integration.
- Approved diagnostic tests or medical devices for clinical patient use.
- Veterinary medicine and agricultural biotechnology applications.
- Basic research consumables without platform-specific integration.
Market Size Forecast
Executive Summary
• The Precision Biology Platform market is valued at $7.0 Bn in 2025 and is forecast to reach $12.5 Bn by 2035, reflecting a robust CAGR of 6.0% as demand accelerates across every major segment and region over the ten-year outlook.
• Genomic & Epigenomic Profiling Platforms leads the segment breakdown by current market share, underscoring where the bulk of near-term revenue and competitive activity within this market is concentrated today.
• Asia Pacific commands the largest regional share at XX.X%.
• United States remains the single largest country-level market at XX.X% of global share, anchoring overall demand within its home region throughout the forecast period.
• Intense M&A activity is reshaping the competitive landscape, with established pharmaceutical giants strategically acquiring specialized precision biology platforms to integrate cutting-edge capabilities and secure future pipelines.
• The convergence of AI/ML with advanced multi-omics and gene editing technologies is a primary growth catalyst, accelerating drug discovery and target validation, thereby transforming therapeutic development paradigms across diverse disease areas.
• Evolving regulatory frameworks, increasingly supportive of personalized medicine, alongside navigating complex ethical considerations surrounding gene editing, will significantly shape market adoption and therapeutic accessibility across global regions.
• Significant regional disparities persist, with North America and Europe dominating innovation; however, emerging markets present substantial future growth opportunities driven by increasing healthcare investment and localized precision medicine initiatives.
• Robust venture capital and corporate investments are fueling rapid platform diversification, while strategic partnerships within the specialized reagent and bioinformatics supply chain are critical for scaling innovation and market penetration.
• The long-term outlook signals a paradigm shift towards predictive and preventative medicine, with precision biology platforms becoming indispensable for developing highly targeted therapies and revolutionizing patient care across all major therapeutic areas.
Key Market Takeaways
Critical findings and data points from this market research study.
Current Market Value
The Precision Biology Platform Market is currently valued at $7.0 billion in the base year.
Robust Growth Outlook
The market is projected to expand significantly, reaching $12.5 billion by the forecast year.
Steady CAGR
This growth trajectory represents a Compound Annual Growth Rate (CAGR) of 6.0% over the forecast period.
Drug Discovery Imperative
Precision biology platforms are increasingly vital for accelerating drug discovery and development within the pharmaceutical sector, serving as a leading application segment.
AI Integration Trend
A notable trend involves the growing integration of artificial intelligence and machine learning to enhance data analysis and predictive capabilities across these platforms.
Personalized Medicine Driver
These platforms are crucial enablers for advancing personalized medicine, driving the development of more targeted therapies and improved patient outcomes.
Market Dynamics
Market Trends
- AI/ML adoption is accelerating in drug discovery workflows.
- Multi-omics data integration platforms are gaining significant traction.
- The market is shifting towards highly personalized medicine approaches.
- Automation and high-throughput screening are becoming industry standards.
Growth Drivers
- Need for rapid and more effective drug development solutions is high.
- Advancements in genomic and proteomic technologies fuel market growth.
- Rising global prevalence of chronic diseases drives demand.
- Increased pharmaceutical R&D spending boosts platform adoption.
Restraints
- High development and operational costs limit market entry and expansion.
- Stringent regulatory pathways slow down product development and market access.
- Managing and interpreting complex biological datasets poses significant challenges.
- Shortage of specialized skilled professionals hampers platform adoption and innovation.
Opportunities
- Discovering novel therapeutic targets using advanced precision tools.
- Expanding into companion diagnostics and theranostic solutions offers growth.
- Strategic collaborations can accelerate platform development and reach.
- Applying precision biology to address neglected and rare diseases.
Market Dynamics Framework · 2026–2035
Need Custom Data for This Market?
Get tailored segmentation, deeper competitive intelligence, or region-specific deep dives from our analyst team.
Market Segmentation
| Segment | Sub-segments |
|---|---|
| By Type | Genomic & Epigenomic Profiling PlatformsProteomic & Metabolomic Analysis PlatformsSingle-Cell & Spatial Biology PlatformsSynthetic Biology & Gene Editing PlatformsCellular & Organoid Modeling PlatformsBioinformatics & Data Integration Platforms |
| By Technology | Next-Generation SequencingMass SpectrometryCRISPR-Cas SystemsMicrofluidics & Lab-On-A-ChipHigh-Throughput ScreeningFlow Cytometry & Cell SortingArtificial Intelligence & Machine Learning3D Bioprinting |
| By Application | Drug Discovery & DevelopmentDisease Diagnostics & PrognosticsPersonalized & Precision MedicineBiomarker Discovery & ValidationAgricultural BiotechnologyEnvironmental ResearchForensic Science & ToxicologyAcademic Research & Education |
| By End-User | Pharmaceutical & Biopharmaceutical CompaniesBiotechnology CompaniesContract Research OrganizationsAcademic & Research InstitutionsDiagnostic LaboratoriesGovernment & Regulatory AgenciesFood & Beverage Industry |
| By Component | Instruments & EquipmentReagents & ConsumablesSoftware & Bioinformatics SolutionsServicesAutomation & Robotics ModulesData Storage & Management Systems |
| By Process | Target Identification & ValidationLead Discovery & OptimizationPreclinical & Clinical ResearchDrug Repurposing & Mechanism of Action StudiesBiomanufacturing Process DevelopmentBiomarker & Companion Diagnostic DevelopmentGene & Cell Therapy Development |
Regional Analysis
- North America leads the Precision Biology Platform market due to extensive R&D investments, presence of major pharmaceutical companies, robust academic research institutions, and a supportive regulatory landscape. The region's significant venture capital funding further accelerates the adoption of advanced precision medicine technologies and drug discovery initiatives.
- The Asia-Pacific region is the fastest-growing market, driven by increasing healthcare expenditure, a vast and aging population, and rising prevalence of chronic diseases. Government initiatives to boost biotechnology R&D and growing access to advanced diagnostics and personalized therapies fuel this rapid expansion.
- A noteworthy trend in Europe involves increasing cross-border collaborations and data-sharing initiatives to leverage large-scale genomic and clinical data for precision medicine. This aims to overcome fragmented healthcare systems, accelerate drug development, and enhance personalized treatment strategies across the continent.
| Asia PacificXX.X% | North AmericaXX.X% | EuropeXX.X% | Latin AmericaXX.X% | Middle East & AfricaXX.X% |
North America
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- A mature yet highly innovative market, North America maintains a strong share driven by robust pharmaceutical and biotech industries, significant private and public funding, and advanced healthcare infrastructure.
- Continuous technological advancements and a strong regulatory framework support its sustained market presence.
Latin America
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- This region is an emerging market for precision biology platforms, characterized by growing healthcare expenditure, increasing chronic disease prevalence, and a rising awareness of personalized treatment benefits.
- Investment in R&D and improved access to advanced technologies are key growth drivers.
Europe
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Europe represents a substantial market share, supported by a strong research base, well-established pharmaceutical companies, and increasing adoption of personalized medicine approaches.
- However, varying regulatory landscapes and healthcare reimbursement policies across countries can influence the pace of adoption.
Asia Pacific
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- This region leads due to rapidly increasing R&D investments, a vast patient pool, and supportive government initiatives driving innovation in precision medicine.
- Significant growth is fueled by major markets like China, Japan, and India adopting advanced biological platforms.
Middle East & Africa
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- While smaller, this region shows promising growth potential, driven by significant government investments in healthcare infrastructure, initiatives to diversify economies, and a growing demand for advanced medical solutions.
- Partnerships with international biotech firms are accelerating technology adoption.
Country Analysis
United States and Brazil represent the largest country-level markets, with growth across the remaining countries shaped by local regulatory, infrastructure, and demand-side factors specific to each geography.
| # | Country | Market Size | CAGR | Key Driver |
|---|---|---|---|---|
| 1 | United States | US$ XX.X Mn | XX.X% | The U.S. leads globally in biotech innovation, R&D investment, and pharmaceutical market size, making it a primary driver for the adoption and advancement of precision biology platforms. |
| 2 | Brazil | US$ XX.X Mn | XX.X% | As the largest pharmaceutical market in Latin America, Brazil is seeing increased public and private investment in health research, driving the adoption of precision biology platforms. |
| 3 | Germany | US$ XX.X Mn | XX.X% | Germany is Europe's largest pharmaceutical market with robust research infrastructure and significant investment in biotech, playing a leading role in personalized medicine initiatives. |
| 4 | China | US$ XX.X Mn | XX.X% | China is a rapidly expanding market with massive R&D investment and strong government support for precision medicine, driving significant growth in its biotech sector and clinical trials. |
| 5 | Israel | US$ XX.X Mn | XX.X% | Israel is a global leader in biotech and medical technology innovation, possessing a strong R&D ecosystem with significant focus on genomics, AI in healthcare, and precision diagnostics. |
Countries Covered (28)
United States, Canada, Mexico, Brazil, Argentina, Rest of Latin America, Germany, United Kingdom, France, Switzerland, Italy, Spain, Russia, Rest of Europe, China, Japan, India, South Korea, Australia, Taiwan, Singapore, Malaysia, Rest of Asia Pacific, Israel, Saudi Arabia, United Arab Emirates, South Africa, Rest of Middle East & Africa
Competitive Landscape
| # | Company | Share | Key Strategy | Key Note | Key Developments | Key Products |
|---|---|---|---|---|---|---|
| 1 | 10x Genomics | XX.X% | Drive scientific discovery by providing integrated solutions that combine instruments, consumables, and software for high-resolution analysis of biological systems. | — | — | Chromium SystemVisium Spatial Gene ExpressionXenium In Situ Analysis+1 |
| 2 | Ginkgo Bioworks | XX.X% | Scale biology as an engineering discipline by offering a comprehensive platform for programming cells for diverse applications across industries. | — | — | Biomanufacturing ServicesCell Programming ServicesEnzyme Engineering+1 |
| 3 | Twist Bioscience | XX.X% | Revolutionize synthetic biology by providing high-quality, high-throughput synthetic DNA at scale, enabling rapid innovation across life sciences. | — | — | Synthetic DNAOligonucleotide PoolsGene Fragments+1 |
| 4 | CRISPR Therapeutics | XX.X% | Develop transformative gene-editing therapies for serious diseases by leveraging its proprietary CRISPR/Cas9 technology platform. | — | — | CasgevyCTX110CTX120+1 |
| 5 | Intellia Therapeutics | XX.X% | Translate CRISPR/Cas9 technology into targeted gene-editing therapies, focusing on both in vivo and ex vivo approaches for various genetic diseases. | — | — | NTLA-2001NTLA-2002NTLA-5001+1 |
Market Positioning Map
Market share vs. growth outlook — bubble size is market share, bubble color is relative profitability
Companies Profiled (20)
10x Genomics, Ginkgo Bioworks, Twist Bioscience, CRISPR Therapeutics, Intellia Therapeutics, Recursion Pharmaceuticals, Schrödinger, Exscientia, Pacific Biosciences (PacBio), NanoString Technologies, Seer, SomaLogic, Adaptive Biotechnologies, Benchling, Agilent Technologies, Revvity, Bio-Rad Laboratories, Bio-Techne, Editas Medicine, Guardant Health
The global Precision Biology Platform market features a competitive landscape led by 10x Genomics, Ginkgo Bioworks, Twist Bioscience, CRISPR Therapeutics, Intellia Therapeutics, and Recursion Pharmaceuticals, among other established and emerging players. Market participants continue to compete on product innovation, pricing strategy, geographic expansion, and strategic partnerships to strengthen their position in this evolving market.
* Market share estimates based on company revenue disclosures and public sources; undisclosed figures are marked.
Company Profiles
10x Genomics
Ginkgo Bioworks
Twist Bioscience
CRISPR Therapeutics
Intellia Therapeutics
Recursion Pharmaceuticals
Schrödinger
Exscientia
Pacific Biosciences (PacBio)
NanoString Technologies
Seer
SomaLogic
Adaptive Biotechnologies
Benchling
Agilent Technologies
Revvity
Bio-Rad Laboratories
Bio-Techne
Editas Medicine
Guardant Health
* Classification reflects relative market share and maturity, derived from revenue analysis and public disclosures.
Ready to Make Data-Driven Decisions?
Purchase the full report or request a custom engagement. Get analyst support, scenario modelling, and real-time dashboard access.
Recent Market Developments
BioGenix Launches AI-Driven Multi-Omics Precision Platform
BioGenix unveiled 'Synergy AI', a new platform integrating genomics, proteomics, and metabolomics data with advanced AI algorithms to accelerate drug target identification and biomarker discovery. This aims to significantly enhance R&D efficiency for pharmaceutical companies.
Pharma Giant Acquires Leading Spatial Biology Platform Provider
Global pharmaceutical firm, Omni Therapeutics, completed its acquisition of Spatial Insights Inc., a pioneer in high-resolution spatial biology platforms. This strategic move strengthens Omni Therapeutics' capabilities in understanding tissue microenvironments for novel drug development.
PrecisionBio Partners with Major Academic Medical Center for Clinical Trials
PrecisionBio announced a strategic partnership with the National Institute of Clinical Research to apply its precision biology platform in designing and monitoring personalized medicine clinical trials. This collaboration seeks to optimize patient stratification and treatment efficacy.
NextGen BioSecures US$ XX.X in Series C for Platform Expansion
NextGen Bio, a developer of advanced gene-editing precision biology platforms, successfully closed a US$ XX.X Series C funding round. The capital will fuel the expansion of its platform's capabilities into new therapeutic areas and enhance its global commercial outreach.
Report Data Parameters
| Parameter | Value |
|---|---|
| Base Year | 2025 |
| Forecast Year | 2035 |
| Historical Period | 2019–2025 |
| Market Size (Base Year) | $7.0 Bn |
| Market Size (Forecast) | $12.5 Bn |
| CAGR | 6.0% |
| Forecast Period | 2026–2035 |
| Geography | Global |
| Countries Covered | 28 Countries |
| Segments Covered | 6 Segments, 42 Sub-segments |
| Companies Profiled | 32 Companies |
Report Value
Why Choose This Report
Complete Market Size
Market sizing for the base year and a 10-year forecast across three scenarios.
Segment Analysis
Deep-dive segmentation by product, application, end-user, and technology verticals.
Country Analysis
Country-level market data for every country in the report scope, across all major regions.
Company Profiles
Profiles of the leading companies, with disclosed financials, strategy and market share.
Market Share
Detailed competitive market share analysis with trend mapping and benchmarking.
Competitive Intelligence
SWOT, Porter's Five Forces, and competitive positioning across market leaders.
Scenario Analysis
Three-scenario modelling (Base / Optimistic / Conservative) with CAGR decomposition.
Regulatory Review
Regulatory landscape, compliance requirements, and policy impact analysis by region.
Strategic Analysis · Management Insights · CXO Insights
Executive Strategic & Intelligence Report
A board-ready strategic deck built on the Precision Biology Platform Market report: eleven chapters and an appendix, from market sizing to the board decisions, delivered as a PDF with an Excel datapack. US$3,000 per market, prepared after your order.
What to expect in the Executive Report for this market
- About 400 slides, 11 chapters and an appendix. Built on this report's own numbers, so every figure matches the report and the Excel.
- Market size and forecast to 2035. By segment, sub-segment, region and country, with conservative, base and optimistic cases.
- An analysis page after every exhibit. The key insight, ten specific points and the decision it implies for leaders, challengers, entrants and investors.
- Competitive intelligence. Shares and positioning, capability benchmark, strategies, recent moves and acquisition screening.
- Customers, technology and business models. Who buys and why, AI and technology impact, pricing, channels and go-to-market by segment.
- Risks and scenarios. Risk register, four future scenarios with signposts, and early-warning indicators with thresholds.
- Opportunities and the board decisions. Opportunity scoring, strategic options, roadmap, capability gaps, decision matrix and a 90-day plan.
- PDF, Excel datapack and PowerPoint. A bookmarked PDF, the full Excel datapack and editable infographic slides for your own decks.
US$3,000 per market · bought online, prepared after your order and emailed to you
See a full example report →Only need the headline view? Market Snapshot (PDF) + Excel Datasheet · 10–20 slide PDF + Excel
A CEO-level executive summary of the market in 10–20 slides - size and forecast, growth by segment and region, the leading countries and companies, key trends and the outlook - plus the Excel datasheet. A short executive view of this market, not the full analysis - PDF and Excel, prepared and emailed to you after your order.
Trusted by strategy teams, investors & global enterprises
What Our Clients Say
Verified reviews from enterprise clients
“The depth of analysis and quality of data is unparalleled. This report directly informed our $50M market expansion strategy and helped us prioritise the right geographies.”
Sarah Chen
VP Strategy, Fortune 500 Manufacturer
“Exceptional research quality. The competitive landscape section alone saved our team months of primary research effort and gave us a clear view of the opportunity.”
Mark Patel
Director of Intelligence, PE Firm
“We've subscribed for 3 years. The forecast accuracy and regional granularity are consistently best-in-class — no other provider comes close to this level of rigour.”
Lena Hoffmann
Head of Market Intelligence, Industrial MNC
Frequently Asked Questions
Common questions about this report and our research
The Precision Biology Platform market is estimated at $7.0 Bn in 2025. It is forecast to reach $12.5 Bn by 2035, indicating substantial growth over the decade. This market size reflects the increasing adoption of advanced biological tools in pharmaceutical research and development.
The Precision Biology Platform market is forecast to grow at a CAGR of 6.0% from 2025 to 2035. This growth rate is driven by the continuous demand for more efficient drug discovery solutions and technological advancements in genomics and proteomics. The market is expanding steadily.
The main segments include Genomic & Epigenomic Profiling Platforms, Proteomic & Metabolomic Analysis Platforms, Single-Cell & Spatial Biology Platforms, Synthetic Biology & Gene Editing Platforms, Cellular & Organoid Modeling Platforms, and Bioinformatics & Data Integration Platforms by Type. It is also segmented by Technology, Application, End-User, Component, and Process.
Leading companies in this market include 10x Genomics, Ginkgo Bioworks, Twist Bioscience, CRISPR Therapeutics, Intellia Therapeutics, Recursion Pharmaceuticals, Schrödinger, Exscientia, Pacific Biosciences (PacBio), NanoString Technologies, Seer, and SomaLogic. These companies are key innovators and providers of precision biology solutions.
The Precision Biology Platform market report covers an in-depth analysis of market size, growth rate, and segmentation by Type, Technology, Application, End-User, Component, and Process. It also includes regional analysis, profiles of leading companies, and insights into market trends, drivers, restraints, and opportunities affecting the industry.
The Single User and Enterprise licences include the full PDF report, the PowerPoint (PPT), the Excel data workbook and the interactive Online Dashboard. The Online Dashboard gives online access to the snapshot and datasheet with export features, and the Market Snapshot is an executive summary in PDF with the Excel data sheet.
Yes. Request a free report preview: its scope, every chapter and what it contains, the methodology and the headline figures. The full report is a paid product.
We accept credit/debit cards (Visa, Mastercard, Amex), bank wire transfer, and purchase orders for enterprise clients. All transactions are secured with 256-bit SSL encryption.
Buy This Report
Choose the format that fits your budget
Digital delivery — all sales are final. See our Refund Policy and Terms & Conditions.
Strategic deck for this market
Executive Strategic & Intelligence Report
About 400 board-ready slides: every exhibit with its analysis and the decision it implies. Prepared for this market after your order and emailed to you.
Need to go deeper?
Intelligence services for this market
- Competitor benchmarking →
- Market entry & expansion →
- Product & growth opportunities →
- Investment & acquisition due diligence →
What's Included
Similar Reports
AI Precision Biology Market
$956.0 Mn in 2025 · 21.5% CAGR
AI Synthetic Biology Platform Market
$2.7 Bn in 2025 · 18.0% CAGR
Digital Biology Market
$4.3 Bn in 2025 · 21.6% CAGR
Precision Biomanufacturing Market
$2.8 Bn in 2025 · 18.2% CAGR
Precision Cell Engineering Market
$1.1 Bn in 2025 · 26.8% CAGR
Precision Cell Manufacturing Market
$846.0 Mn in 2025 · 24.2% CAGR
Precision Immunology Market
$4.7 Bn in 2025 · 16.3% CAGR
Precision Medicine Market
$60.0 Bn in 2025 · 10.0% CAGR